临床试验/NCT04812145

NCT04812145Unknown不适用

Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma

Assiut University0 个研究点目标入组 50 人开始时间: 2021年4月1日最近更新: 2021年3月23日

适应症

试验速览

阶段: 不适用
发起方: Assiut University
入组人数: 50
主要终点: Response to hypofractionated radiotherapy concurrent with Gemcitabine in urinary bladder cancer

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Estimate the response to modified hypofractionated radiotherapy concurrent with Gemcitabine in urinary bladder cancer patients .

Estimate local control, relapse free survival, overall survival and bladder preservation rate. Evaluate the toxicity of a modified hypofractionated chemoradiotherapy protocol for patients with invasive bladder cancer.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

•Pathologically confirmation of transitional cell carcinoma . Non metastatic invasive bladder cancer (TNM0) Any age group ≥ 18 years. Non pregnant female patients.

排除标准

•Other pathology than Transitional cell carcinoma Metastatic Patient Age less than 18 years

结局指标

主要结局

Response to hypofractionated radiotherapy concurrent with Gemcitabine in urinary bladder cancer

时间窗: baseline

Estimate Disease free survival .

次要结局

未报告次要终点

研究者

发起方

Assiut University

申办方类型

Other

责任方

Principal Investigator

主要研究者

Esraa Mostafa Abdelzaher Mohamed

Principal Investigator

Assiut University

相似试验

Unknown

2 期

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial TumorThymoma and Thymic Carcinoma

NCT03663764Sun Yat-sen University57

已完成

2 期

Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.Unresectable Pancreatic CancerNonmetastatic Pancreatic CancerLocally Advanced Pancreatic Cancer

NCT02035072Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori40

已完成

3 期

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLCCarcinoma, Small CellLung Neoplasms

NCT02688036Cancer Institute and Hospital, Chinese Academy of Medical Sciences860

已完成

2 期

Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLCNon-small Cell Lung Cancer

NCT03900117Sun Yat-sen University77

Unknown

2 期

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRCColorectal Neoplasms

NCT05292417The First Affiliated Hospital of Xiamen University71